Form 4: STAAR Surgical Director Lou Silverman Receives Equity Award

STAAR Surgical Co. Director Lou Silverman was granted 10,683 restricted stock units as part of the company's non-employee director equity compensation program.

Summary

• Lou Silverman, a Director of STAAR Surgical Co. (STAA), received an equity award on June 18, 2025.
• The award consists of 10,683 Restricted Stock Units (RSUs), with each RSU representing the right to receive one share of the Corporation's common stock upon vesting.
• These equity awards were granted pursuant to the Corporation's annual non-employee director equity compensation program for the 2025-2026 term.
• The RSUs vest in full on the earlier of June 18, 2026, or the Corporation's 2026 Annual Meeting of Shareholders.

Sentiment

Score: 6

Explanation: The filing reports a routine equity grant to a director as part of their compensation, which is a neutral to slightly positive event as it aligns director interests with shareholders without indicating any unusual or significant operational changes.

Positives

• The grant of equity awards to a director aligns their financial interests with those of the shareholders, promoting long-term value creation.

Future Outlook

The granted Restricted Stock Units are set to vest in 2026, indicating a future commitment and alignment of the director's interests with the company's long-term performance.

Management Comments

• The equity awards were granted to the Reporting Person on June 18, 2025, pursuant to the Corporation's annual non-employee director equity compensation program for the 2025-2026 term.

Industry Context

The compensation of non-employee directors with equity awards, such as Restricted Stock Units, is a common and standard practice across publicly traded companies. This approach is widely adopted to align the interests of board members with those of the company's shareholders, encouraging long-term value creation and responsible governance.

Comparison to Industry Standards

• The grant of Restricted Stock Units to a non-employee director is a standard practice within the industry for compensating board members and aligning their interests with shareholder value. This is consistent with compensation structures observed in comparable companies within the medical device and ophthalmic industries.

Corporate Governance

Related Party Transactions

• Grant of 10,683 Restricted Stock Units to Lou Silverman, a Director of STAAR Surgical Co., as part of his compensation for the 2025-2026 term.

Stakeholder Impact

• Shareholders: The equity grant aligns the director's financial incentives with the company's stock performance, potentially benefiting shareholders through improved governance and strategic decisions.
• Employees: No direct impact on employees is mentioned in this filing.

Next Steps

• Vesting of the 10,683 Restricted Stock Units on the earlier of June 18, 2026, or the Corporation's 2026 Annual Meeting of Shareholders.

Key Dates

Keywords

STAAR Surgical, STAA, Form 4, SEC filing, Restricted Stock Units, RSU, equity compensation, director compensation, insider transaction, corporate governance